Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.
Find out what a historical investment in Biodexa Pharmaceuticals PLC would be worth today using our BDRX stock calculator.
Buying BDRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Biodexa Pharmaceuticals PLC in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BDRX
What is the ticker symbol of Biodexa Pharmaceuticals PLC?
The ticker symbol for Biodexa Pharmaceuticals PLC is BDRX.
How much is one share of BDRX?
One share of BDRX is valued at $2.00 as of 20 November 2026.
What is the market capitalisation of Biodexa Pharmaceuticals PLC BDRX?
As of 20 November 2026 Biodexa Pharmaceuticals PLC has a market cap of $1.07M.
What is the 52-week high for Biodexa Pharmaceuticals PLC stock?
The Biodexa Pharmaceuticals PLC 52-week high stock price is $357.60.
What is the 52-week low for Biodexa Pharmaceuticals PLC stock?
The Biodexa Pharmaceuticals PLC 52-week low stock price is $1.95.
Can I buy BDRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BDRX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BDRX on Stake
Buy BDRX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of BDRX from only US$10 with fractional shares